文献速递脑血管病

胰岛素抵抗患者的缺血性卒中肥胖悖论

Obesity-Stroke Paradox Exists in Insulin-Resistant Patients But Not Insulin Sensitive Patients.
PubMed 文献 · Stroke · 2019-05-02

该研究基于中国急性卒中糖代谢异常登记研究,纳入1227例无糖尿病史的缺血性卒中患者,按体重指数≥23定义超重或肥胖,以稳态模型胰岛素抵抗指数中位数1.9定义胰岛素抵抗。结果显示,在胰岛素抵抗患者中超重或肥胖者1年死亡风险显著低于低/正常体重者(9.42% vs 17.69%,未校正HR 0.50,95%CI 0.31-0.82),而胰岛素敏感患者中无此差异(7.58% vs 6.91%,HR 1.07,95%CI 0.57-1.99),且体重指数与胰岛素抵抗对死亡风险存在显著交互作用(P=0.045)。

要点

  • 胰岛素抵抗的缺血性卒中患者中,超重或肥胖与1年死亡风险降低相关。
  • 胰岛素敏感患者中未观察到肥胖悖论。
  • 体重指数与胰岛素抵抗对死亡风险存在显著交互作用(P=0.045)。

核心结论

  • 在胰岛素抵抗的缺血性卒中患者中观察到肥胖悖论,而胰岛素敏感患者中未观察到。
  • 胰岛素抵抗可能是缺血性卒中肥胖悖论的机制之一。

研究设计与样本

  • 基于中国急性卒中糖代谢异常登记研究,纳入无糖尿病史的缺血性卒中患者1227例。
  • 超重或肥胖定义为体重指数≥23,胰岛素抵抗以稳态模型胰岛素抵抗指数中位数1.9为切点。
  • 采用Cox或logistic回归模型评估体重指数与胰岛素抵抗对1年预后(全因死亡和不良功能结局)的交互作用。

主要发现

  • 胰岛素抵抗患者中,超重或肥胖者死亡风险为低/正常体重者的一半(9.42% vs 17.69%,未校正HR 0.50,95%CI 0.31-0.82)。
  • 胰岛素敏感患者中,超重或肥胖与低/正常体重者死亡风险无显著差异(7.58% vs 6.91%,HR 1.07,95%CI 0.57-1.99)。
  • 不良功能结局呈现相似趋势,校正混杂因素后结果相似。
  • 体重指数与胰岛素抵抗对死亡风险(P=0.045)和不良功能结局(P=0.049)存在显著交互作用。

关键数值与推荐

  • 超重或肥胖定义为体重指数≥23。
  • 胰岛素抵抗定义为稳态模型胰岛素抵抗指数≥中位数1.9(四分位距1.1-3.1)。
  • 不良功能结局定义为改良Rankin量表评分3-6分。

临床怎么用

  • 对缺血性卒中患者评估胰岛素抵抗可能有助于识别肥胖悖论适用人群。
  • 胰岛素抵抗患者中较高的体重指数未必提示预后更差,临床决策需结合代谢状态综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- The underlying mechanisms of stroke-obesity paradox are still not fully understood. This study aims to investigate the contribution of insulin resistance to the association between body mass index and stroke outcomes. Methods- Patients with ischemic stroke without history of diabetes mellitus in the Abnormal Glucose Regulation in Patients With Acute Stroke Across-China registry were included. Overweight or obese was defined as body mass index ≥23, and the median of homeostasis model assessment-insulin resistance index was chosen as cutoff to define insulin resistance. Cox or logistic regression model was used to assess the interaction between body mass index and homeostasis model assessment-insulin resistance on 1-year prognosis (all-cause mortality and poor functional outcome defined as modified Rankin Scale score 3-6). Results- Of 1227 study participants, the median homeostasis model assessment-insulin resistance was 1.9 (interquartile range, 1.1-3.1) and 863 (70.3%) patients were classified as overweight or obese. Among insulin-resistant patients, overweight/obese patients experienced one-half of the risk of death after stroke than their low/normal weight counterparts (9.42% versus 17.69%, unadjusted hazard ratio, 0.50; 95% CI, 0.31-0.82), while among insulin-sensitive ones, no significant difference of mortality risk was found (7.58% versus 6.91%, 1.07; 0.57-1.99). Similar trends were observed for poor functional outcome. Results were similar after adjustments for confounders. There were significant interactions between body mass index and homeostasis model assessment-insulin resistance on the risks of mortality (P=0.045) and poor functional outcome (P=0.049). Conclusions- We observed the obesity paradox for mortality and functional outcome in insulin-resistant patients but did not find the obesity paradox in insulin-sensitive patients. Insulin resistance may be one of the mechanisms underlying the obesity paradox of the outcome in patients with ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Xu J, Wang A, Meng X, et al. Obesity-Stroke Paradox Exists in Insulin-Resistant Patients But Not Insulin Sensitive Patients. Stroke. 2019. PMID: 31043152. doi:10.1161/STROKEAHA.118.023817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。